[ Price : $8.95]
FDA issues Botanix Pharmaceuticals a complete response letter on its NDA for sofpironium bromide gel, indicated for treating prima...[ Price : $8.95]
FDA posts a draft guidance with recommendations on how animal drug sponsors may voluntarily establish a defined duration of use fo...[ Price : $8.95]
Reuters says its analysis of FDA regulatory actions shows an agency crackdown on companies that fail to sufficiently test cough sy...[ Price : $8.95]
The Justice Department says a Florida man pleaded guilty to one count of conspiracy to introduce adulterated and misbranded HIV dr...[ Price : $8.95]
Federal Register notice: FDA announces an 11/30 public workshop entitled Advancing the Development of Pediatric Therapeutics (ADEP...[ Price : $8.95]
Vanda Pharmaceuticals asks the DC federal court to order FDA to vacate its corner-cutting approval of an MSN ANDA for a generic fo...[ Price : $8.95]
Novartis says the Phase 3 NETTER-2 trial met its primary endpoint of improvement in progression-free survival and the key secondar...[ Price : $8.95]
FDA reviewers say clinical data submitted in a BrainStorm Cell Therapeutics BLA for Lou Gehrigs Disease treatment NurOwn do not de...